USPTO serial 79410428
UPCON
Reviewed by CopyMark Law Group
Status 653
- Filing date
- Status date
- Registration date
- —
- Examiner
- LEE, OLIVIA SUNMIN
- Law office
- TMO LAW OFFICE 128
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with UPCON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark E. Olds
Mark E. Olds Muncy, Geissler, Olds & Lowe, P.C.125 S Royal StreetAlexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical compositions and materials for use in science; chemical reagents for laboratory use, other than for medical or veterinary use; diagnostic reagents and preparations, except for medical or veterinary use; diagnostic reagents, other than for medical laboratory use; diagnostic reagents for scientific or research use; reagents for research purposes; reagents for scientific purposes; reagents for industrial purposes; fluorescent chemical preparations, being label molecules, that can be conjugated with biomolecules to make them visible in experiments, for scientific or research use; reagents for laboratory purposes, other than for medical or veterinary purposes; chemicals for use in scientific research, other than medical or veterinary; biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; reagents for use with analyzers, other than for medical or veterinary purposes; reagents for use in analytical tests, other than for medical or veterinary purposes; diagnostic reagents, other than for medical use for sale in kit form; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic preparations, other than for medical or veterinary purposes; diagnostic preparations for scientific or research use; immunoassay reagents, other than for medical use; chemical reagents for use in genetic research; buffer solutions for scientific purposes; reference standards being chemicals for use in science; chemically treated test strips for nonmedical scientific purposes; chemical paper for use with assays; test paper, chemical; antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; indicators being chemicals for scientific use; calibration fluids for medical apparatus; chemically treated nonmedical test strips for calibration of laboratory apparatus; calibration fluids for optical readers; reagent strips for scientific or research use; biochemical reagents used for non-medical purposes; chemical preparations for use as standards and reference materials in research and analysis | ACTIVE | — |
| 005 | Diagnostic preparations for medical, veterinary, forensic, environmental and food safety analysis purposes; diagnostic substances for medical use; diagnostic biomarker reagents for medical purposes; biological reagents for veterinary use; biological reagents for medical use; diagnostic reagents for medical use; veterinary diagnostic reagents; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; medical diagnostic test strips for testing bodily fluids; reagent paper for medical or veterinary purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use; immunoassay reagents for medical use | ACTIVE | — |
| 009 | Testing apparatus for testing biochemical agents not for medical purposes; diagnostic apparatus for analyzing nucleic acids, proteins, peptides or glycans, not for medical purposes; scientific research and laboratory apparatus, namely, optical readers with built-in dispensers, and optical readers with or without temperature control; laboratory apparatus and instruments, namely, microplates, fluid dispensers, incubators, and microplate shakers, automated laboratory equipment in the nature of laboratory robots, optical filters for laboratory analyzers and optical readers, the foregoing not for medical use; microplate readers; apparatus for measuring time-resolved fluorometry, upconverting nanoparticle technology, fluorescence, fluorescence polarization, luminescence, and absorbance; electronic nonmedical imaging devices for microplate, immunoassay test strip and microscope slide imaging; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; imaging devices for scientific purposes, namely, portable and handheld digital electronic devices for microplate, immunoassay test strip and microscope slide imaging; fluorescence photometers; luminescence analyzers, namely, luminescence photometers; nanoparticle size analyzers; optical readers; downloadable and recordable computer software for monitoring and controlling laboratory apparatus and instruments; downloadable and recordable computer software for processing and reporting measurement results of optical readers, immunoassay and nucleic acid analyzers and for carrying out result interpretation algorithms; downloadable and recordable computer software for laboratory analyzers and microplate readers for use in medical decision support systems for clinical use; downloadable or recordable computer software for operating medical and veterinary apparatus and instruments; downloadable or recordable computer software for operating laboratory apparatus and instruments; photomultiplier tubes | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments for infectious disease testing, namely, respiratory infections, eye infections, topical infections, gastrointestinal infections, vector-borne diseases, zoonotic diseases, sexually transmitted infections, blood-borne infections, fungal infections, parasitic infections, prion diseases, urinary track infections, diagnostics of cardiovascular diseases, and cancer diagnostics; diagnostic apparatus for use in medical analysis for analyzing infectious diseases, namely, respiratory infections, eye infections, topical infections, gastrointestinal infections, vector-borne diseases, zoonotic diseases, sexually transmitted infections, blood-borne infections, fungal infections, parasitic infections, prion diseases, urinary tract infections; apparatus for carrying-out diagnostic tests for medical purposes for testing biomarkers for infectious agents or cancer in bodily fluids, namely, blood, lymphatic fluid, urine, sweat, tears, saliva, feces, bile, mucus, broncho-alveolar lavage fluid, semen, vaginal secretions, amniotic fluid, cerebrospinal fluid, synovial fluid, pericardial fluid, pleural fluid, peritoneal fluid, and breast milk; diagnostic, examination, and monitoring equipment, namely, nucleic acid amplification and analysis apparatus, immunoassay processing and analysis apparatus, used for biomolecule detection and analysis in clinical laboratories; diagnostic apparatus for medical purposes, namely, apparatus for testing biomarkers for infectious agents, cancer and benign diseases in bodily fluids; diagnostic testing platforms for clinical laboratory medicine for testing biomarkers for infectious agents or cancer in bodily fluids and tissue specimens; Diagnostic testing platforms for the analysis of bodily fluids for testing biomarkers for infectious agents or cancer; immunological analysers being medical diagnostic instruments for the analysis of tissue specimens or bodily fluids, namely, blood, lymphatic fluid, urine, sweat, tears, saliva, feces, bile, mucus, broncho-alveolar lavage fluid, semen, vaginal secretions, amniotic fluid, cerebrospinal fluid, synovial fluid, pericardial fluid, pleural fluid, peritoneal fluid or breast milk for the qualitative, semi-quantitative or quantitative detection of antibodies, antigens, proteins, peptides, glycoproteins or toxins; testing apparatus being medical diagnostic instruments for the analysis of tissue specimens or bodily fluids, namely, blood, lymphatic fluid, urine, sweat, tears, saliva, feces, bile, mucus, broncho-alveolar lavage fluid, semen, vaginal secretions, amniotic fluid, cerebrospinal fluid, synovial fluid, pericardial fluid, pleural fluid, peritoneal fluid or breast milk for the qualitative, semi-quantitative or quantitative detection of antibodies, antigens, proteins, peptides, glycoproteins, toxins or nucleic acids; diagnostic imaging apparatus for medical use, namely, medical diagnostic imaging apparatus for microplate, immunoassay test strip and microscope slide imaging | ACTIVE | — |
| 042 | Scientific research in the fields of in vitro diagnostics, forensics, veterinary diagnostics, environmental analysis and food safety analysis; industrial analysis and research services in the fields of diagnostic preparations and biotechnology instrumentation; science and technology services, namely, research in the field of diagnostic assays; Science and technology services, namely, product development services in the fields of in vitro diagnostics, forensics, veterinary diagnostics, environmental analysis and food safety analysis; Consultancy services relating to assay development in the fields of cancer, cancer prediction, cancer prevention, cancer diagnosis, in vitro diagnostics, forensics, veterinary diagnostics, environmental analysis and food safety analysis; scientific laboratory services; analytical laboratory services in the fields of diagnostics, forensics, veterinary diagnostics, environmental analysis and food safety analysis; medical research laboratory services; research laboratory services in the field of immunoassay and lectin binding assay testing; preparation of immunohistological samples for analysis in research laboratories; preparation of biological samples for testing and analysis in research laboratories; platform as a service (PaaS) services featuring computer software platforms for processing and analyzing measurement results of optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; software as a service (SaaS) services featuring computer software for analyzing and reporting of measurement results from optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; Software development, programming and implementation, particularly, engineering consultancy services relating to hardware and software development in the field of life sciences; design and development of computer database software; consultancy services relating to quality control for others; engineering consultancy relating to testing; rental of laboratory apparatus and instruments | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 25, 2026 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 25, 2026 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 25, 2026 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 16, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 20, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 20, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 12, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 12, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 21, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 21, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 26, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 24, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 21, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |